Syed, Farooq
Tersey, Sarah A.
Turatsinze, Jean-Valery
Felton, Jamie L.
Kang, Nicole Jiyun
Nelson, Jennifer B.
Sims, Emily K.
Defrance, Mathieu
Bizet, Martin
Fuks, Francois
Cnop, Miriam
Bugliani, Marco
Marchetti, Piero
Ziegler, Anette-Gabriele
Bonifacio, Ezio
Webb-Robertson, Bobbie-Jo
Balamurugan, Appakalai N.
Evans-Molina, Carmella
Eizirik, Decio L.
Mather, Kieren J.
Arslanian, Silva
Mirmira, Raghavendra G. http://orcid.org/0000-0002-5013-6075
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (UC4 DK104166, R01 DK093954, R01 DK060581, R01 DK105588, K24 HD01357, P30 DK097512, P30 DK020595)
National Center for Advancing Translational Sciences (UL1 TR000005)
Juvenile Diabetes Research Foundation United States of America
Article History
Received: 4 May 2020
Accepted: 14 July 2020
First Online: 31 July 2020
Ethics approval and consent to participate
: All samples were collected with informed consent by the patients or their legal parents/guardians. Studies were approved by the Bayerische Landesaerztekammer, the Ludwig-Maximilians University, the University of Pittsburgh, and the Indiana University Institutional Review Boards.
: RGM, DLE, FF, and SAT have filed a patent application for assays to measure β cell dysfunction and death.